The Diagnosis and Management of Cutaneous Lymphomas

  • M. F. Spittle
Part of the New Clinical Applications book series (NCDM, volume 7)


The diseases presenting as cutaneous lymphoma are fascinating, showing a wide diversity of natural history, clinical appearances and response to treatment. These diseases are rare, but can often confidently be clinically segregated into the varying types of cutaneous lymphoma. The clinical and histopathological classifications have been facilitated by recent advances in immunocytochemistry.


Mycosis Fungoides Sezary Syndrome Cutaneous Lymphoma Superficial Mycosis PUVA Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Edelson, R.L. (1980). Cutaneous T cell lymphoma: Mycosis fungoides, Sézary syndrome and other variants. J. Am. Acad. Dermatol., 2, 89PubMedCrossRefGoogle Scholar
  2. 2.
    Wood, G.S. (1983). The immunologic and clinicopathologic heterogeneity of cutaneous lymphomas other than mycosis fungoides. Blood, 62, 464PubMedGoogle Scholar
  3. 3.
    Spittle, M.F. (1977). Mycosis fungoides: electron beam therapy. Bull. Cancer (Paris), 64, 305Google Scholar
  4. 4.
    Alibert, J.L.M. (1806). Descriptions des Maladies de la Peau: Observées a l’Hôpital St Louis et Exposition des Meilleures Méthodes Suivies pour leur Traitement. (Paris: Barrois l’Aine et Fils), p. 157Google Scholar
  5. 5.
    Bazin, E. (1870). Leçons sur le Traitement des Maladies Chroniques en Generales Affections de la Peau en Particulier par l’Emploi comparé des Eaux minerales de l’Hydrotherapie et des Moyens Pharmaceutiques p.425. (Paris: Adrien Delahaye)Google Scholar
  6. 6.
    Vidal, E and Brocq, L. (1885). Étude sur 6 mycosis fungoide. Fr. Medical 21, 946Google Scholar
  7. 7.
    Besnier, E. and Hallopeau, H. (1892). On the erythroderma of mycosis fungoides. J. Cutan. GenitoUrin. Dis. 10, 453Google Scholar
  8. 8.
    Worringer, F. and Kolopp, P. (1939). Lesion erythemato-squameuse polycy-clique de l’avant bras évoluant depuis 6 ans chez un garconnet de 13 ans. Ann. dermatologie Venerologie, 7, 945Google Scholar
  9. 9.
    Sézary, A. and Bouvrain, Y. (1938). Erythrodermie avec presence de cellules monstreuses dans le derme et le sang circulant. Bull. Soc. Fr. Dermatol. Syph., 45, 254Google Scholar
  10. 10.
    Lutzner, M.A. and Jordan, J.W. (1968). The ultrastructure of an abnormal cell in Sézary syndrome. Blood, 31, 719PubMedGoogle Scholar
  11. 11.
    Bunn, Jr, P.A. and Lambery, S.I. (1979). Report of the committee on staging and classification of cutaneous T cell lymphomas. Cancer Treat. Rep. 63, 725PubMedGoogle Scholar
  12. 12.
    Cohen, S.R. (1980). Mycosis fungoides: clinicopathologic relationships, survival and therapy in 59 patients with observations on occupation as a new prognostic factor. Cancer 46, 2654PubMedCrossRefGoogle Scholar
  13. 13.
    Norris, D.A. and LeFeber, W.P. (1939). Mycosis fungoides and the Sézary. Thiers, B.H. and Dobson, R.L. (eds.). Pathogenesis of skin disease. (New York: Churchill Livingstone)Google Scholar
  14. 14.
    Grossman, B., Schechter, G.P., Horton, J.E., et al. (1981). A proposal for smoldering adult T cell lymphoma-leukemia. Am. J. Clin. Pathol., 75, 149PubMedGoogle Scholar
  15. 15.
    Berger, CL., Rehle, T., Friedman-Kien, A.E., et al. (1984). Common membrane antigen on lymphocytes from cutaneous T-cell lymphoma and acquired immune deficiency syndrome patients (Abs). Clin. Res, 32, 571AGoogle Scholar
  16. 16.
    Robert-Guroff, M. and Gallo, R.C. (1983). Establishment of an etiologic relationship between the human T cell leukemia lymphoma virus (HTLV) and adult T cell leukemia. Blut, 47, 5CrossRefGoogle Scholar
  17. 17.
    Castellino, R. and Hoppe, R.T. (1979). Experience with lymphography in patients with mycosis fungoides. Cancer Treat. Rep., 63, 581PubMedGoogle Scholar
  18. 18.
    Fuks, Z. and Bagshaw, M.A. (1973). Prognostic signs and the management of mycosis fungoides. Cancer, 32, 1385PubMedCrossRefGoogle Scholar
  19. 19.
    Gilchrest, B.A. and Parrish, J.A. (1976). Oral Methoxsalen photochemotherapy of mycosis fungoides. Cancer, 38, 683PubMedCrossRefGoogle Scholar
  20. 20.
    Logan, R.A., Spittle, M.F. and Smith, N.P. (1986). Photochemotherapy for cutaneous T-cell lymphomas — the St John’s experience. Br. J. Derm., 115, Suppl. 30, 17Google Scholar
  21. 21.
    Bratherton, D.G. (1972). Strontium beam therapy. In Deeley, T.J. (ed.) Modern Trends in Radiotherapy. (London: Butterworths)Google Scholar
  22. 22.
    Vonderheid, E.C. and Van Scott, E.J. (1979). A 10 year experience with topical mechlorethamine for mycosis fungoides: comparison with patients treated by total-skin electron beam radiation therapy. Cancer Treat. Rep. 63, 681PubMedGoogle Scholar
  23. 23.
    Hoppe, R.T., Cox, R.S., Fuks, Z., et al. (1979). Electron beam therapy for mycosis fungoides: the Stanford University experience. Cancer Treat. Rep. 63, 691PubMedGoogle Scholar
  24. 24.
    Hoppe, R.T., Fuks, Z. and Bagshaw, M.A. (1977). The rationale for curative radiotherapy in mycosis fungoides. Int. J. Radiat. Oncol., 2, 843CrossRefGoogle Scholar
  25. 25.
    Grozea, P.N. and Jones, S.E. (1979). Combination chemotherapy for mycosis fungoides: A Southwest Oncology Group study. Cancer Treat. Rep. 63, 647PubMedGoogle Scholar
  26. 26.
    Edelson, R.L., Berger, C, Gasparro, F., et al. (1983). Treatment of leukemic cutaneous T cell lymphoma with extracorporeally photoactivated 8-methoxypso-ralen (abs). Clin. Res., 31, 467AGoogle Scholar
  27. 27.
    Braun-Falco, O., Burg, G. and Schmoeckel, C.H. (1981). Recent advances in the understanding of cutaneous lymphoma. Clin. Exp. Dermatol. 6, 89PubMedCrossRefGoogle Scholar
  28. 28.
    Rappaport, H. (1966). Tumors of the hematopoietic system. In Atlas of Tumour Pathology, 3, 8. (Washington DC: US Armed Forces Institute of Pathology)Google Scholar
  29. 29.
    Lukes, R.J. and Collins, R.D. (1974). Immunological characterization of human malignant lymphomas. Cancer, 34, 1488PubMedCrossRefGoogle Scholar
  30. 30.
    Lennert, K. and Mori, N. (1974). The histopathology of malignant lymphomas. Cancer, 34, 1488CrossRefGoogle Scholar
  31. 31.
    Bennett, M.H., Farrer-Brown, G. and Henry, K. (1974). Classification of non-Hodgkin’s lymphomas. Lancet, 2, 405CrossRefGoogle Scholar
  32. 32.
    Coltman, Jnr, C.A. et al. (1977). Chemotherapy of non-Hodgkin’s lymphoma: 10 years’ experience in the Southwest Oncology Group. Cancer Treat. Rep. 61, 1067PubMedGoogle Scholar
  33. 33.
    Miller, R.A., Maloney, D.G. and Warnke, R. (1982). Treatment of B cell lymphoma with monoclonal anti-idiotype antibody. N. Engl. J. Med. 306, 577CrossRefGoogle Scholar
  34. 34.
    Burg, G. and Braun-Falco, O. (1983). Cutaneous lymphomas. Pseudolymphomas and related disorders. (Berlin: Springer-Verlag)Google Scholar
  35. 35.
    Weinman, V.F. and Ackerman, A.B. (1981). Lymphomatoid papulosis: A critical review and new findings. Am. J. Dermatol. 3, 129CrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1988

Authors and Affiliations

  • M. F. Spittle

There are no affiliations available

Personalised recommendations